Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Clinical trial NCT04189588 · COMPLETED

Trial details

NCT number: NCT04189588
Sponsor: TerSera Therapeutics LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Oncology Patients Receiving Chemotherapy

Start date: 2020-03-25
Primary completion: 2020-11-23
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.